IMPORTANCE Acinic cell carcinoma is a rare salivary neoplasm that is generally associated with a good prognosis, although a subset of patients develops local and distant recurrences. Given the rarity of the disease, factors to identify patients at risk for recurrences or decreased survival are not clearly defined.
approximately 3% to 9% of all salivary gland neoplasms and up to 17% of salivary gland malignant neoplasms. 2, 4 Most
ACCs occur in the parotid gland and infrequently involve the minor salivary and submandibular glands. 2, 5 Although most ACCs are composed of several cell types, the predominant cell variety is acinic serous cells with zymogensecreting granules. 2 Although early controversies questioned the malignant nature of acinic cell tumors because of their slow growth patterns, pathologic features, and clinical behavior, several studies 6, 7 demonstrated the propensity of this tumor for lymphatic and distant metastasis. Initial studies on ACC indicated that histologic grade had little significance as a predictor of prognosis, yet more recent studies 4, 5, 8 have found that high-grade malignant neoplasms are associated with advanced-stage disease, higher incidence of distant metastasis, and poorer 5-year survival.
Because of the rarity of this disease, few studies 5, 9, 10 have comprehensively assessed the prognosis of ACC with respect to risk factors, histologic features, stage, site, and treatment. The goals of this study were to identify clinicopathologic factors associated with adverse survival in patients with ACC and to assess the effect of local, regional, and distant recurrences on survival.
Methods
After approval from the institutional review board of The University of Texas MD Anderson Cancer Center, a retrospective medical record review identified 155 patients who were treated for ACC from January 1990 through February 2013. The primary outcomes assessed were overall and disease-free survival. The end points studied to assess these outcomes included sex, age at diagnosis, disease status at time of presentation, T stage, N stage, size of primary tumor, the presence of positive surgical margins, the extent of surgery, and the addition of postoperative radiation therapy. In addition, the effect of the site of a recurrence on overall survival was evaluated. Persistent disease was defined as a patient with incomplete or inadequate initial therapy that required a revision procedure to achieve the surgical standard of care. Positive surgical margins were defined as macroscopically or microscopically positive or close margin less than 5 mm. The indications for radiation therapy in this series were recurrent disease, positive surgical margins, presence of cervical lymph nodes, perineural invasion, high-grade tumors, and T3 or T4 primaries. All tumors were assessed by a head and neck pathologist. Odds ratios and 95% CIs were calculated to assess the odds of death from disease. The χ 2 test or Fisher exact test was used to assess significance for an association between the patient characteristics and death from disease. Univariate Cox proportional hazards regression models were built to estimate the hazard ratios and 95% CIs of the prognostic factors considered for overall survival and disease-free survival. 11 The proportional hazards assumptions were checked. Multivariate models adjusting for prognostic factors were built using the Cox proportional hazards regression model. To identify the most significant predictors, models including all variables were initially fitted and then reduced in a stepwise manner to identify the best fit according to the Akaike information criterion. 12 The likelihoods of the full and reduced model were compared using the χ 2 test
to decide whether the additional variable present in the full model significantly improved the fit. Predictors with P<.05 were considered to be statistically significant. All statistical analyses were performed with R version 3.0.0 statistical software (Lucent Technologies Inc) using a Mac OS X 10.8.4 computer (Apple Corp).
Results

Demographics
One hundred fifty-five patients were identified, with a mean follow-up of 6.8 years (range, 0.2-38 years). The mean age at presentation was 52 years (range, 11-100 years). Ninety-six patients were older than 45 years, and 59 patients were 45 years or younger. Female patients were twice as likely to have ACC compared with male patients ( Table 1) . Given the high referral rate seen at The University of Texas MD Anderson Cancer Center, most patients presented with persistent (54.1%) or recurrent disease (29.0%) ( Table 1) . Most patients presented with parotid masses, whereas only 3.X% of neoplasms arose from the submandibular gland, and most patients presented with stage I and II disease (Table 1) . For cases where tumor dimensions were available, lesions smaller than 3 cm were slightly more common than larger tumors ( Table 1) . As expected for ACC, nodal metastases were rarely identified.
Treatment
Patients underwent a spectrum of surgical procedures, most commonly a superficial parotidectomy (54.1%). However, given the high rate of recurrent and persistent disease in this series, a substantial number of patients underwent total parotidectomies (39.1%) ( Table 1) . Neck dissection was performed in 25.9% of patients. Pathologically, close or positive surgical margins were observed in nearly half of the patients. Adjuvant radiation therapy was administered to 50.7% of patients.
Outcomes
Patients older than 45 years had a significantly decreased overall and disease-free survival compared with their younger counterparts (P = .02 and .03, respectively) ( Figure 1A and B). These survival differences appeared to be due to a higher incidence of distant metastases that was seen in the older population ( Figure 1C ). Although ACC is more common in the female population, women had an improved overall survival, independent of stage, and were less likely to die of their disease (Tables 1, 2, 3, and 4). The presence of persistent disease did not have an effect on survival, whereas the development of a recurrence portended an adverse prognosis, with decreased diseasefree survival and an increased likelihood of death from disease (Tables 1 through 4) . Among patients who presented with cervical lymphadenopathy, there was an increased risk of death from disease compared with patients with N0 disease (Table 4) . Patients with stage I and II disease not only had significantly improved overall and diseasefree survival but also had a decreased risk of death from disease ( Figure 2 and Tables 1 through 4 ). The size of the primary tumor appeared to be equivalently prognostic of sur v ival as clinic al stage bec ause patients w ith tumors larger than 3 cm had a significantly decreased survival compared with patients with smaller tumors (Figure 2A and B). The extent of the surgery for the primary tumor did not affect overall or disease-free survival (Table 1 , 2, and 3). Furthermore, the likelihood of developing a local recurrence was equivalent whether the patient underwent a superficial or total parotidectomy (odds ratio, 1.31; 95% CI, 0.55-3.12; P = .54) ( Table 5 ). Despite the low frequency of regional disease, the addition of the neck dissection reduced the regional recurrence rate from 9% to 2% (Table 4 ). The presence of positive surgical margins did not affect survival or local recurrence (Tables 1, 2, 3, and 5 ). The addition of postoperative radiation did not improve overall or disease-free survival, and there was no effect on local or regional recurrences for patients treated for recurrent disease (Table 1, 2,  3 , and 5), likely reflecting the nature of the patient population in this study.
With multimodality therapy, we observed a local control rate of 80%, with 31 patients developing a recurrence (Table 5) . Patients older than 45 years (n = 96) have a decreased overall (A) and disease-free survival (B) with an increased rate of distant metastases (DM) (C) compared with patients 45 years and younger (n = 59). Log rank tests confirmed that the overall and disease-free survival curves were significantly different (P = .02 and .03, respectively). The curve for time to distant metastases was not statistically significant (P = .14).
Prior recurrence was predictive of the development of another recurrence, and patients in this study with recurrent disease were 9-fold more likely to develop another local recurrence. The regional control rates were greater than 90%, with nodal failure occurring in only 11 patients (7.1%), and the presence of previous recurrence was predictive for additional regional recurrences (Table 5) . Distant failure was observed in 30 patients (19.4%), most commonly in the lungs. In contrast to local and regional recurrences, distant recurrences were associated not only with previously recurrent disease but also age older than 45 years (Table 5) . Furthermore, 13 patients (8.4%) died of their disease, with most of these deaths due to the development of distant metastases (76.9%, Table 4 ). The mean time to death from disease was 3.8 years (range, 0.7-11.2 years).
Discussion
Acinic cell carcinoma is a rare neoplasm that is generally classified as a low-grade salivary gland malignant neoplasm, with an estimated 5-year, disease-specific survival of more than 90%. 5 Although most patients have a favorable prognosis, there is a small population who will ultimately succumb to their disease. 5 Given the rarity of the disease, it remains difficult to identify which patients are at highest risk of death from their disease. Moreover, prior studies evaluating patients enrolled in regional and national tumor registries are complicated by nonstandardized treatment modalities. In the current study, we evaluated factors that were predictive of adverse outcomes among patients with ACC treated with a unified treatment strategy at a single institution.
In this study, we identified age as a critical predictor of outcome for ACC where older age is associated with decreased survival, which corroborates the findings of earlier studies. 5 A novel discovery in the current study is that the decreased survival experienced by older patients appeared to be due to the development of distant metastases rather than age-related medical comorbidities. It has been reported that both increasing age and distant metastases are associated with increased risk of death from disease, but there has not been a previous link between age and the development of distant metastases. 5 The sex preference toward females has been reported in prior studies, although the percentage of females affected in this series is slightly higher. Furthermore, females have not only a more favorable prognosis than males, with 10-year overall and disease-free survival rates of 80% and 42%, respectively, but also are less likely to die of their disease. Taken together, it appears female patients are more likely to be afflicted with ACC but have more favorable overall outcomes. The underlying biologic mechanisms for this phenomenon are not apparent.
Although most patients seen at our institution had presented with recurrent or persistent disease, no effect on overall survival was observed. However, disease-free survival was adversely affected among those patients with recurrent disease, and there was a higher likelihood of localregional and distant metastasis. Not surprisingly, they were also more likely to die of their disease. Thus, these findings identify recurrent disease as a significant negative prognostic factor and emphasize the importance of appropriate initial management of ACC. This conclusion is supported by the outcomes of untreated or incompletely treated patients cared for at our institution, where only 11.8% developed a recurrence and resulted in only 2 disease-related deaths (1.7%).
As expected, patients with early-stage disease demonstrated improved survival and decreased risk of death from disease compared with patients with advanced-stage disease. Although clinical staging has prognostic value, only a small percentage of patients presented with stage III and IV disease. Alternatively, when we grouped lesions with a 3-cm cut- comprehensive parotid dissection, with a large percentage of the patients presenting with recurrent disease necessitating a total parotidectomy (39.1%). Despite the aggressive management of the primary site in both recurrent and persistent cases, 
